Search results
Found 8 matches for
Pancreatic cancer immune map provides clues for precision treatment targeting
7 February 2025
Study shows why there are differences in prognosis between different pancreatic tumours and identifies potential avenues for improved treatment approaches.
Study uncovers how cancer stem cells spread and resist treatment
6 June 2024
NDORMS researchers have identified a critical axis that controls the formation and behaviour of cancer stem cells (CSCs), a subpopulation of cells that influence how lethal the cancer can be, its resistance to chemotherapy, and its ability to spread to other parts of the body.
NDORMS researchers join new multidisciplinary oncology research project
12 October 2021
OPTIMA aims to improve treatment for patients with prostate, breast and lung cancer through artificial intelligence
Plastic surgeons recommend a review of cancer excision guidelines after finding variations in effectiveness
15 December 2020
A systematic review finds Incomplete excision rates for basal cell carcinoma range from 4.7% to 20.4% against recommended guidelines of 5%.
Researchers call for an urgent return to skin cancer surgery
27 November 2020
In a research letter to the British Journal of Surgery (BJS) a team of plastic surgeons reveal the effect of the COVID-19 pandemic on skin cancer surgery in the UK.
IL-22 pathway linked to poor prognosis in colon cancer
18 August 2020
Research shows how IL-22 interacts with KRAS mutant tumours to promote excessive growth in colorectal cancer
New collaboration will help researchers understand why cancer survival between patients differs
27 January 2020
NDORMS researchers join five other universities to investigate how cancer survivors make antibodies that target and destroy tumours, and explore routes for new treatments
Cancer progression may be controlled by targeting tumor-specific extracellular matrix
15 January 2020
Researchers have uncovered how tumors exploit tenascin-C to deflect the body’s natural defence against them.